MIMICS

K073468 · Materialise NV · LLZ · Apr 2, 2008 · Radiology

Device Facts

Record IDK073468
Device NameMIMICS
ApplicantMaterialise NV
Product CodeLLZ · Radiology
Decision DateApr 2, 2008
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.2050
Device ClassClass 2
AttributesSoftware as a Medical Device

Intended Use

The Materialise Mimics software is intended for use as a software interface and image segmentation system for the transfer of imaging information from a medical scanner such as a CT scanner or a Magnetic Resonance Imaging scanner to an output file. It is also intended as pre-operative software for simulating / evaluating surgical treatment options. Mimics is not intended to be used for mammography imaging.

Device Story

Mimics software functions as interface and image segmentation system; processes medical imaging data (CT or MRI scans). Transforms raw scan data into output files; enables pre-operative simulation and evaluation of surgical treatment options. Used by clinicians in clinical settings; software-based tool. Output assists healthcare providers in surgical planning and decision-making; potential patient benefit through improved pre-operative assessment. Not for mammography.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Software-based image processing and segmentation system. Inputs: CT/MRI imaging data. Outputs: Digital files for surgical simulation. Non-sterile. No specific hardware requirements or connectivity standards detailed.

Indications for Use

Indicated for use as a software interface and image segmentation system for transferring medical imaging data (CT/MRI) to output files and for pre-operative simulation/evaluation of surgical treatment options. Not indicated for mammography imaging.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K073468 # 510(K) SUMMARY OF SAFETY AND EFFECTIVENESS MIMICS (Materialise's Interactive Medical Image Control System) #### PROPRIETARY NAME: Mimics APR - 2 2008 ## COMMON NAME: Image processing system and preoperative software for simulating surgical treatment options ### CLASSIFICATION NAME: System, Image Processing. This product uses images acquired from Computerized Tomography (CT) or Magnetic Resonance Imaging (MRI) scanners. ### DEVICE CLASSIFICATION: This device has been classified as Class II. ### REGULATORY CLASS: Class II Product Code: LLZ SUBMITTER'S NAME AND ADDRESS: # MATERIALISE N.V. Technologielaan 15 B-3001 Leuven, Belgium ESTABLISHMENT REGISTRATION NO: 3003998208 Contact Person: Mieke Janssen, Materialise N.V. Quality Engineer Summary Preparation Date: April 1, 2008 ### PREDICATE DEVICE The Mimics software is claimed to be substantially equivalent in material, design, and function to the SimPlant product from Materialise Dental which was cleared by FDA under 510(k) K033849 on May 25, 2004. ### Device Description The Materialise Mimics software is intended for use as a software interface and image segmentation system for the transfer of imaging information from a medical scanner such as a CT scanner or a Magnetic Resonance Imaging scanner to an output file. It is also intended as pre-operative software for simulating / evaluating {1}------------------------------------------------ surgical treatment options. Mimics is not intended to be used for mammography imaging. #### STERILIZATION The Mimics product is provided non-sterile. #### INDICATIONS FOR USE The Materialise Mimics software is intended for use as a software interface and image segmentation system for the transfer of imaging information from a medical scanner such as a CT scanner or a Magnetic Resonance Imaging scanner to an output file. It is also intended as pre-operative software for simulating / evaluating surgical treatment options. Mimics is not intended to be used for mammography imaging. #### SUBSTANTIAL EQUIVALENCE Mimics is considered to be substantially equivalent to the SimPlant System. ## CONCLUSION Mimics is considered to be substantially equivalent in design, material and function to the SimPlant system. {2}------------------------------------------------ # DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized depiction of an eagle or bird-like figure with three curved lines forming its body and wings. The logo is surrounded by text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850 APR - 2 2008 Mr. Mieke Janssen Quality Engineer Materialise NV Technologielaan 15 3001 Leuven BELGIUM Re: K073468 Trade/Device Name: Mimic Software Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: March 20, 2008 Received: March 24, 2008 Dear Mr. Janssen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Image /page/2/Picture/10 description: The image is a circular logo with the letters "FDA" in the center. Above the letters, the numbers "1906 - 2006" are displayed. Below the letters, the word "Centennial" is written in cursive. The logo is surrounded by a circle of stars. Protecting and Promoting Public Health {3}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter. | 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 | |-----------------|----------------------------------|--------------| | 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 | | 21 CFR 892.xxxx | (Radiology) | 240-276-0120 | | Other | | 240-276-0100 | Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Nancy C. Brogdon Nancy C. Brogdon Director, Division of Reproductive. Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Page 2 Enclosure {4}------------------------------------------------ # Indications for Use 510(k) Number (if known): K073468 Device Name: Mimics Indications For Use: Mimics is intended for use as a software interface and image segmentation system for the transfer of imaging information from a medical scanner such as a CT scanner or a Magnetic Resonance Imaging scanner to an output file. It is also used as pre-operative software for simulating /evaluating surgical treatment options. Mimics is not intended to be used for mammography imaging. A Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED). Concurrence of CDRH, Office of Device Evaluation (ODE) Arznhnh (Division Sign-Division of Reproductive, Abdominal, and Radiological Device 510(k) Number Page 1 of
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%